Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study.
Employment
Recovery
Recurrence
Resilience
Substance use disorder
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
04 05 2021
04 05 2021
Historique:
accepted:
21
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
23
11
2021
Statut:
epublish
Résumé
Resilience, referring to the inherent ability to naturally recover in the face of adverse conditions, is an essential concept in discussions of substance use disorder (SUD) recovery. This study's objective was to shed light on resilience and related factors that affect relapse risk in patients with SUDs. Fifty-two patients with SUDs were given a self-administrated questionnaire from February to April 2015 consisting of question items for sociodemographic characteristics, relapse risk (Stimulant Relapse Risk Scale), and resilience (Bidimensional Resilience Scale). Scale scores were tested for associations with subject attributes, after which resilience's effects on relapse risk were analyzed using correlation and multiple regression (forced-entry) analyses. Stimulants were the most common substance related to SUD (n = 26, 21.7%; multiple answers). Bivariate correlation showed that higher acquired resilience was significantly associated with a lower relapse risk (r = - 0.314, P < 0.01). Reduced relapse risk was significantly associated with current employment (Std. β = - 0.446, P < 0.05). Our findings demonstrate the necessity of recovery support to enhance acquired resistance in patients with SUDs to prevent relapses. Reinforcing employment support services and encouraging patients to continue treatment were suggested as potentially effective measures to enhance resilience in individuals with SUDs on their road to recovery.
Sections du résumé
BACKGROUND
Resilience, referring to the inherent ability to naturally recover in the face of adverse conditions, is an essential concept in discussions of substance use disorder (SUD) recovery. This study's objective was to shed light on resilience and related factors that affect relapse risk in patients with SUDs.
METHOD
Fifty-two patients with SUDs were given a self-administrated questionnaire from February to April 2015 consisting of question items for sociodemographic characteristics, relapse risk (Stimulant Relapse Risk Scale), and resilience (Bidimensional Resilience Scale). Scale scores were tested for associations with subject attributes, after which resilience's effects on relapse risk were analyzed using correlation and multiple regression (forced-entry) analyses.
RESULTS
Stimulants were the most common substance related to SUD (n = 26, 21.7%; multiple answers). Bivariate correlation showed that higher acquired resilience was significantly associated with a lower relapse risk (r = - 0.314, P < 0.01). Reduced relapse risk was significantly associated with current employment (Std. β = - 0.446, P < 0.05).
CONCLUSION
Our findings demonstrate the necessity of recovery support to enhance acquired resistance in patients with SUDs to prevent relapses. Reinforcing employment support services and encouraging patients to continue treatment were suggested as potentially effective measures to enhance resilience in individuals with SUDs on their road to recovery.
Identifiants
pubmed: 33947412
doi: 10.1186/s13011-021-00377-8
pii: 10.1186/s13011-021-00377-8
pmc: PMC8097930
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
40Subventions
Organisme : kaken
ID : 15K11835
Références
Child Abuse Negl. 2007 Mar;31(3):205-9
pubmed: 17408738
J Addict Dis. 1994;13(4):129-41
pubmed: 7734464
JAMA Psychiatry. 2015 Apr;72(4):303-4
pubmed: 25651391
J Nerv Ment Dis. 2002 Nov;190(11):737-45
pubmed: 12436013
Work. 2015;50(3):425-32
pubmed: 25248531
Pharmacol Biochem Behav. 2018 Jan;164:4-21
pubmed: 28942119
Soc Work. 1998 Jul;43(4):297-308
pubmed: 9663000
Psychiatry Res. 2020 Feb;284:112702
pubmed: 31839418
Drug Alcohol Depend. 2007 May 11;88(2-3):174-81
pubmed: 17118576
J Consult Clin Psychol. 2009 Apr;77(2):229-42
pubmed: 19309183
Trends Cogn Sci. 2014 Apr;18(4):211-7
pubmed: 24612993
Trials. 2020 Feb 11;21(1):167
pubmed: 32046765
Front Psychiatry. 2019 Jun 12;10:388
pubmed: 31249535
Mil Med. 2012 May;177(5):517-24
pubmed: 22645877
J Subst Abuse Treat. 1998 Nov-Dec;15(6):493-8
pubmed: 9845862
Medicina (Kaunas). 2012;48(10):544-51
pubmed: 23324251
J Psychoactive Drugs. 2018 Apr-Jun;50(2):177-186
pubmed: 29125424
Health Inf Manag. 1997 Mar-May;27(1):31-8
pubmed: 10169442
Subst Abuse Rehabil. 2018 Nov 16;9:103-114
pubmed: 30532612
Am J Orthopsychiatry. 1987 Jul;57(3):316-331
pubmed: 3303954
Arch Psychiatr Nurs. 1996 Oct;10(5):276-82
pubmed: 8897710
J Addict Med. 2013 May-Jun;7(3):189-95
pubmed: 23609211
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Jun;43(3):172-87
pubmed: 18646643
Am Psychol. 2001 Mar;56(3):227-38
pubmed: 11315249
Child Dev. 2000 May-Jun;71(3):543-62
pubmed: 10953923
Yonago Acta Med. 2016 Dec 26;59(4):279-287
pubmed: 28070165
J Consult Clin Psychol. 1991 Apr;59(2):295-304
pubmed: 2030191
J Psychoactive Drugs. 2013 Jan-Mar;45(1):28-38
pubmed: 23662329
Child Abuse Negl. 2007 Mar;31(3):211-29
pubmed: 17399786
Exp Clin Psychopharmacol. 2014 Feb;22(1):75-85
pubmed: 24490712
Front Psychiatry. 2018 Oct 16;9:436
pubmed: 30386257